Literature DB >> 1399420

Preliminary evaluation of flicker sensitivity as a predictive test for exudative age-related maculopathy.

M J Mayer1, S J Spiegler, B Ward, A Glucs, C B Kim.   

Abstract

Flicker contrast sensitivity was tested in the "good" eyes of 13 patients with monocular exudative age-related maculopathy (ARM). The stimulus was a foveal, long-wavelength, low spatial frequency 2.8 degrees circle in an equiluminant (photopic) surround. Two of these ARM-risk eyes have since developed exudative ARM. Compared to healthy age-matched eyes, the two eyes that developed exudative ARM had significantly lower sensitivity at 10-40 Hz up to 9 mo before exudative symptoms appeared. The implications of these results regarding the time-course of ARM and the predictive value of foveal contrast sensitivity testing are considered. Based upon data and theoretical considerations, the authors speculate that sensitivity loss between 10 and 40 Hz is a good predictor of which eyes will develop exudative ARM. This proposal will be tested by new data from current as well as new ARM-risk subjects.

Entities:  

Mesh:

Year:  1992        PMID: 1399420

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  10 in total

1.  Improved contrast of subretinal structures using polarization analysis.

Authors:  Stephen A Burns; Ann E Elsner; Mariane B Mellem-Kairala; Ruthanne B Simmons
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-09       Impact factor: 4.799

Review 2.  [Practical significance of critical fusion frequency (CFF). Chronological resolution of the visual system in differential diagnosis].

Authors:  H Baatz; P Raak; D de Ortueta; A Mirshahi; G Scharioth
Journal:  Ophthalmologe       Date:  2010-08       Impact factor: 1.059

3.  Characteristics of the normative database for the Humphrey matrix perimeter.

Authors:  Andrew John Anderson; Chris A Johnson; Murray Fingeret; John L Keltner; Paul G D Spry; Michael Wall; John S Werner
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-04       Impact factor: 4.799

4.  The effect of pre-adapting light intensity on dark adaptation in early age-related macular degeneration.

Authors:  Allannah J Gaffney; Alison M Binns; Tom H Margrain
Journal:  Doc Ophthalmol       Date:  2013-07-17       Impact factor: 2.379

5.  The value of multifocal electroretinography to predict progressive visual acuity loss in early AMD.

Authors:  L Ambrosio; G Ambrosio; G Nicoletti; G de Crecchio; B Falsini
Journal:  Doc Ophthalmol       Date:  2015-07-02       Impact factor: 2.379

6.  Measuring visual function in age-related macular degeneration with frequency-doubling (matrix) perimetry.

Authors:  Andrew John Anderson; Chris A Johnson; John S Werner
Journal:  Optom Vis Sci       Date:  2011-07       Impact factor: 1.973

7.  A practical method of measuring the human 
temporal contrast sensitivity function.

Authors:  Billy R Wooten; Lisa M Renzi; Robert Moore; Billy R Hammond
Journal:  Biomed Opt Express       Date:  2010-07-14       Impact factor: 3.732

Review 8.  Beneficial effects of saffron (Crocus sativus L.) in ocular pathologies, particularly neurodegenerative retinal diseases.

Authors:  Jose A Fernández-Albarral; Rosa de Hoz; Ana I Ramírez; Inés López-Cuenca; Elena Salobrar-García; María D Pinazo-Durán; José M Ramírez; Juan J Salazar
Journal:  Neural Regen Res       Date:  2020-08       Impact factor: 5.135

9.  Visual Function in Eyes with Intermediate AMD with and without Retinal Pigment Abnormalities.

Authors:  Marilyn E Schneck; Lori A Lott; Gunilla Haegerstrom-Portnoy; Susan Hewlett; Bonnie M Gauer; Ali Zaidi
Journal:  Optom Vis Sci       Date:  2021-01-01       Impact factor: 2.106

10.  Simple Vision Function Tests that Distinguish Eyes with Early to Intermediate Age-related Macular Degeneration.

Authors:  Lori A Lott; Marilyn E Schneck; Gunilla Haegerstrom-Portnoy; Susan Hewlett; Natalie Stepien-Bernabe; Bonnie M Gauer; Ali Zaidi; Arthur D Fu; John A Brabyn
Journal:  Ophthalmic Epidemiol       Date:  2020-08-12       Impact factor: 1.648

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.